Exela Pharma Sciences Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
600
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$26M
- Investors
-
14
Exela Pharma Sciences General Information
Description
Provider of sterile injectable and ophthalmic pharmaceutical products intended for the alleviation of drug shortages and the improvement of patient care. The company integrates in-house research and development, clinical manufacturing, and large-scale commercial production of generic and proprietary medicines, utilizing advanced aseptic filling lines and lyophilization suites to generate high-barrier treatments, enabling healthcare providers to secure a reliable domestic supply of critical medications while reducing overall treatment costs through vertically integrated supply chain management.
Contact Information
Website
www.exelapharma.comCorporate Office
- 1245 Blowing Rock Boulevard
- Lenoir, NC 28645
- United States
Corporate Office
- 1245 Blowing Rock Boulevard
- Lenoir, NC 28645
- United States
Exela Pharma Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | 15-Sep-2021 | $26M | Completed | Generating Revenue | ||
| 11. Debt - PPP | 14-Apr-2020 | Completed | Generating Revenue | |||
| 10. Debt - General | 18-Sep-2018 | Completed | Generating Revenue | |||
| 9. Grant | 19-Aug-2016 | Completed | Generating Revenue | |||
| 8. Debt - General | 12-Feb-2016 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 19-Aug-2015 | Completed | Generating Revenue | |||
| 6. Grant | 10-Feb-2014 | Completed | Generating Revenue | |||
| 5. Debt - General | 23-Jul-2013 | Completed | Generating Revenue | |||
| 4. Grant | 03-Jan-2013 | $190K | $10.2M | Completed | Generating Revenue | |
| 3. Debt - General | 21-Jun-2012 | $10.2M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Exela Pharma Sciences Patents
Exela Pharma Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11738841-B2 | Thruster arrangement for a boat | Active | 10-Jun-2019 | ||
| US-20210380210-A1 | Thruster arrangement for a boat | Active | 10-Jun-2019 | ||
| US-10478453-B1 | Stable, highly pure l-cysteine compositions for injection and methods of use | Active | 15-Jan-2019 | ||
| US-10583155-B1 | Stable, highly pure l-cysteine compositions for injection and methods of use | Active | 15-Jan-2019 | ||
| US-10653719-B1 | Stable, highly pure l-cysteine compositions for injection and methods of use | Active | 15-Jan-2019 | A61K31/095 |
Exela Pharma Sciences Signals
Exela Pharma Sciences Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Baruch Future Ventures | Family Office | Minority | ||
| Baystate Health Foundation | Limited Partner | Minority | ||
| Henry Ford Health System | Corporation | Minority | ||
| Memorial Healthcare System | Corporation | Minority | ||
| MercyOne Genesis | Corporation | Minority |
Exela Pharma Sciences FAQs
-
When was Exela Pharma Sciences founded?
Exela Pharma Sciences was founded in 2005.
-
Where is Exela Pharma Sciences headquartered?
Exela Pharma Sciences is headquartered in Lenoir, NC.
-
What is the size of Exela Pharma Sciences?
Exela Pharma Sciences has 600 total employees.
-
What industry is Exela Pharma Sciences in?
Exela Pharma Sciences’s primary industry is Pharmaceuticals.
-
Is Exela Pharma Sciences a private or public company?
Exela Pharma Sciences is a Private company.
-
What is Exela Pharma Sciences’s current revenue?
The current revenue for Exela Pharma Sciences is .
-
How much funding has Exela Pharma Sciences raised over time?
Exela Pharma Sciences has raised $52.6M.
-
Who are Exela Pharma Sciences’s investors?
Baruch Future Ventures, Baystate Health Foundation, Henry Ford Health System, Memorial Healthcare System, and MercyOne Genesis are 5 of 14 investors who have invested in Exela Pharma Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process